Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Bio-Reference Laboratories, Inc. Stockholders

NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP is investigating potential claims against the Board of Directors of Bio-Reference Laboratories, Inc. (“BRLI” or the “Company”) (NASDAQ:BRLI) concerning the proposed acquisition of the Company by OPKO Health, Inc. (“OPKO”). Pursuant to the terms of the definitive merger agreement, BRLI stockholders will receive 2.75 shares of OPKO common stock for each share of BRLI common stock they own, a value of $52.58 per share of BRLI common stock.